Porth Ymchwil

Drug activation carrier: WO 2011/026898-A2

Allbwn ymchwil: Patent

StandardStandard

Drug activation carrier: WO 2011/026898-A2. / Gwenin, Christopher (Dyfeisiwr).
Rhif y patent: US 2012/232328-A1.

Allbwn ymchwil: Patent

HarvardHarvard

Gwenin, C, Drug activation carrier: WO 2011/026898-A2, Rhif y patent US 2012/232328-A1.

APA

Gwenin, C. (2011). Drug activation carrier: WO 2011/026898-A2. (Rhif y patent US 2012/232328-A1).

CBE

Gwenin C, dyfeisydd. 2011. Drug activation carrier: WO 2011/026898-A2. Rhif y patent US 2012/232328-A1.

MLA

Gwenin, Christopher. 2011. Drug activation carrier: WO 2011/026898-A2. Rhif y patent US 2012/232328-A1.

VancouverVancouver

Gwenin C, dyfeisydd. Drug activation carrier: WO 2011/026898-A2. US 2012/232328-A1. 2011.

Author

Gwenin, Christopher (Dyfeisiwr). / Drug activation carrier : WO 2011/026898-A2. Rhif y patent: US 2012/232328-A1.

RIS

TY - PAT

T1 - Drug activation carrier

T2 - WO 2011/026898-A2

AU - Gwenin, Christopher

PY - 2011

Y1 - 2011

M3 - Patent

M1 - US 2012/232328-A1

ER -